Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Airbus finalises deal to take over certain Spirit assets

(Sharecast News) - Airbus and Spirit AeroSystems announced on Monday that they have finalised an agreement to transfer ownership of certain assets and production sites to the European aerospace corporation as part of Spirit's acquisition by Boeing. The agreement will see Airbus take on certain sites from the US supplier in North Carolina, St Nazaire and Casablanca, as well as the production of certain A220 components in Kansas and Belfast, and A320 and A350 components in Prestwick.

Spirit had agreed to be bought by Boeing last summer for $4.7bn, with Airbus agreeing to take ownership of several of Spirit's loss-making operations in Europe.

At the time, a $599m compensation figure had been given, though this was revised lower to $439m due to revised transaction terms.

"For many years, Spirit's collaboration with Airbus allowed us to deliver aerostructures for some of their most important aircraft programs," said Irene Esteves, Spirit's executive vice president and chief financial officer.

"Entering into this agreement is a significant milestone as we work towards the closing of the Boeing acquisition, to the benefit of Spirit, its stockholders and other stakeholders."

The deal will also see Airbus provide Spirit with non-interest bearing lines of credit in an aggregate amount of $200m.

Airbus shares were up 1.7% at €142.92 by 1008 in Paris.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.